Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Description of a novel species of fast growing mycobacterium: Mycobacterium kyogaense sp. nov., a scotochromogenic strain received as Mycobacterium vaccae.

Nouioui I, Brunet LR, Simpson D, Klenk HP, Goodfellow M.

Int J Syst Evol Microbiol. 2018 Dec;68(12):3726-3734. doi: 10.1099/ijsem.0.003039. Epub 2018 Oct 9.

PMID:
30300123
2.

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.

Gnjatic S, Bronte V, Brunet LR, Butler MO, Disis ML, Galon J, Hakansson LG, Hanks BA, Karanikas V, Khleif SN, Kirkwood JM, Miller LD, Schendel DJ, Tanneau I, Wigginton JM, Butterfield LH.

J Immunother Cancer. 2017 May 16;5:44. doi: 10.1186/s40425-017-0243-4. eCollection 2017. Review.

3.

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

Brunet LR, Hagemann T, Andrew G, Mudan S, Marabelle A.

Oncoimmunology. 2015 Dec 18;5(4):e1112942. eCollection 2016 Apr. Review.

4.

Immune monitoring technology primer: immunoprofiling of antigen-stimulated blood.

Brunet LR, LaBrie S, Hagemann T.

J Immunother Cancer. 2016 Mar 15;4:18. doi: 10.1186/s40425-016-0122-4. eCollection 2016. No abstract available.

5.

An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma.

Stebbing J, Dalgleish A, Gifford-Moore A, Martin A, Gleeson C, Wilson G, Brunet LR, Grange J, Mudan S.

Ann Oncol. 2012 May;23(5):1314-9. doi: 10.1093/annonc/mdr363. Epub 2011 Sep 19.

PMID:
21930686
6.

Immune protection against tuberculosis--when is immunotherapy preferable to vaccination?

Grange JM, Brunet LR, Rieder HL.

Tuberculosis (Edinb). 2011 Mar;91(2):179-85. doi: 10.1016/j.tube.2010.12.004. Epub 2011 Jan 12. Review.

PMID:
21233019
7.

Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.

Hernández-Pando R, Aguilar D, Orozco H, Cortez Y, Brunet LR, Rook GA.

Clin Vaccine Immunol. 2008 Nov;15(11):1730-6. doi: 10.1128/CVI.00286-08. Epub 2008 Sep 30.

8.

Mycobacteria and allergies.

Rook GA, Hamelmann E, Brunet LR.

Immunobiology. 2007;212(6):461-73. Epub 2007 Apr 17. Review.

PMID:
17544831
9.

Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior.

Lowry CA, Hollis JH, de Vries A, Pan B, Brunet LR, Hunt JR, Paton JF, van Kampen E, Knight DM, Evans AK, Rook GA, Lightman SL.

Neuroscience. 2007 May 11;146(2):756-72. Epub 2007 Mar 23.

10.

Intradermal injection of heat-killed Mycobacterium vaccae in dogs with atopic dermatitis: a multicentre pilot study.

Ricklin Gutzwiller ME, Reist M, Peel JE, Seewald W, Brunet LR, Roosje PJ.

Vet Dermatol. 2007 Apr;18(2):87-93.

PMID:
17355422
11.

Cytokine Interaction and Immune Responses during Schistosoma mansoni Infection.

Brunet LR, Dunne DW, Pearce EJ.

Parasitol Today. 1998 Oct;14(10):422-7.

PMID:
17040834
12.

Old friends for breakfast.

Rook GA, Brunet LR.

Clin Exp Allergy. 2005 Jul;35(7):841-2. No abstract available.

PMID:
16008666
13.

Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model.

Hunt JR, Martinelli R, Adams VC, Rook GA, Brunet LR.

Clin Exp Allergy. 2005 May;35(5):685-90.

PMID:
15898994
14.

Microbes, immunoregulation, and the gut.

Rook GA, Brunet LR.

Gut. 2005 Mar;54(3):317-20. Review.

15.

Modelling gene-environment interactions in Th1- and Th2-dominated diseases of laboratory animals.

Rook GA, Martinelli R, Brunet LR.

Ernst Schering Res Found Workshop. 2005;(50):45-68. Review. No abstract available.

PMID:
15526936
16.

Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.

Rook GA, Adams V, Hunt J, Palmer R, Martinelli R, Brunet LR.

Springer Semin Immunopathol. 2004 Feb;25(3-4):237-55. Epub 2003 Oct 8. Review.

PMID:
15007629
17.

Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice.

Adams VC, Hunt JRF, Martinelli R, Palmer R, Rook GAW, Brunet LR.

Eur J Immunol. 2004 Mar;34(3):631-638. doi: 10.1002/eji.200324659.

18.

Innate immune responses to mycobacteria and the downregulation of atopic responses.

Rook GA, Martinelli R, Brunet LR.

Curr Opin Allergy Clin Immunol. 2003 Oct;3(5):337-42. Review.

PMID:
14501431
19.

Paneth and intermediate cell hyperplasia induced in mice by helminth infections.

Kamal M, Dehlawi MS, Brunet LR, Wakelin D.

Parasitology. 2002 Sep;125(Pt 3):275-81.

PMID:
12358424
20.

Give us this day our daily germs.

Rook GA, Brunet LR.

Biologist (London). 2002 Aug;49(4):145-9.

PMID:
12167746
21.

Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation.

Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, Pay G, Walker C.

J Immunol. 2002 Aug 1;169(3):1492-9.

22.

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells.

Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C.

Nat Med. 2002 Jun;8(6):625-9.

PMID:
12042815
23.

Dangers of therapeutic manipulation of the Th-Th2 balance.

Brunet LR, Hunt J, Rook GA.

Trends Immunol. 2002 Mar;23(3):127-8. No abstract available.

PMID:
11864836
24.

Profound effect of the absence of IL-4 on T cell responses during infection with Schistosoma mansoni.

Pedras-Vasconcelos JA, Brunet LR, Pearce EJ.

J Leukoc Biol. 2001 Nov;70(5):737-44.

PMID:
11698493
25.

Risk of Lyme disease: perceptions of residents of a Lone Star tick-infested community.

Armstrong PM, Brunet LR, Spielman A, Telford SR 3rd.

Bull World Health Organ. 2001;79(10):916-25.

26.

Nitric oxide in parasitic infections.

Brunet LR.

Int Immunopharmacol. 2001 Aug;1(8):1457-67. Review.

PMID:
11515811
27.

Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independent.

Patton EA, Brunet LR, La Flamme AC, Pedras-Vasconcelos J, Kopf M, Pearce EJ.

Infect Immun. 2001 Jan;69(1):589-92.

28.

Immune responses during the acute stages of infection with the intestinal trematode Echinostoma caproni.

Brunet LR, Joseph S, Dunne DW, Fried B.

Parasitology. 2000 Jun;120 ( Pt 6):565-71.

PMID:
10874719
29.
30.

Schistosoma mansoni: IL-4 is necessary for concomitant immunity in mice.

Brunet LR, Kopf MA, Pearce EJ.

J Parasitol. 1999 Aug;85(4):734-6.

PMID:
10461958
31.

Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice.

Marshall AJ, Brunet LR, van Gessel Y, Alcaraz A, Bliss SK, Pearce EJ, Denkers EY.

J Immunol. 1999 Aug 15;163(4):2089-97.

33.

The initiation and function of Th2 responses during infection with Schistosoma mansoni.

Pearce EJ, La Flamme A, Sabin E, Brunet LR.

Adv Exp Med Biol. 1998;452:67-73. Review.

PMID:
9889961
34.

IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis.

Brunet LR, Finkelman FD, Cheever AW, Kopf MA, Pearce EJ.

J Immunol. 1997 Jul 15;159(2):777-85.

PMID:
9218595
35.

Heterogeneity of Lyme disease spirochaetes within individual vector ticks.

Brunet LR, Spielman A, Fikrig E, Telford SR 3rd.

Res Microbiol. 1997 Jun;148(5):437-45.

PMID:
9765822
36.

Anti-OspA antibody reduces reservoir competence of mice for Borrelia burgdorferi, the agent of Lyme disease.

Brunet LR, Katavolos P, Spielman A, Telford SR 3rd.

Med Vet Entomol. 1997 Apr;11(2):198-200. No abstract available.

PMID:
9226653
37.

Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue.

Das S, Shraga D, Gannon C, Lam TT, Feng S, Brunet LR, Telford SR, Barthold SW, Flavell RA, Fikrig E.

Res Microbiol. 1996 Nov-Dec;147(9):739-51.

PMID:
9296108
38.

IL-4 in schistosomiasis.

Pearce EJ, Vasconcelos JP, Brunet LR, Sabin EA.

Exp Parasitol. 1996 Nov;84(2):295-9. Review.

PMID:
8932780
39.

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

de Silva AM, Telford SR 3rd, Brunet LR, Barthold SW, Fikrig E.

J Exp Med. 1996 Jan 1;183(1):271-5.

40.

Short report: density of Lyme disease spirochetes within deer ticks collected from zoonotic sites.

Brunet LR, Spielman A, Telford SR 3rd.

Am J Trop Med Hyg. 1995 Sep;53(3):300-2.

PMID:
7573717
41.

Antibody response of the mouse reservoir of Borrelia burgdorferi in nature.

Brunet LR, Sellitto C, Spielman A, Telford SR 3rd.

Infect Immun. 1995 Aug;63(8):3030-6.

42.

Borrelia burgdorferi infection is rarely found in patients with chronic fatigue syndrome.

Pollark RJ, Komaroff AL, Telford SR 3rd, Gleit, Fagioli L, Brunet LR, Spielman A.

Clin Infect Dis. 1995 Feb;20(2):467-8. No abstract available.

PMID:
7742458
43.

Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.

Telford SR 3rd, Fikrig E, Barthold SW, Brunet LR, Spielman A, Flavell RA.

J Exp Med. 1993 Aug 1;178(2):755-8.

Supplemental Content

Loading ...
Support Center